Mirvaso OverviewBrimonidine is a drug, used as eye drops under the brand names Alphagan and Alphagan-P to treat open-angle glaucoma or ocular hypertension, as a gel, Mirvaso, for facial skin redness in rosacea, and in tartrate formulation, beginning in July 2018, as an ophthalmic vasoconstrictor, sold by Bausch and Lomb under the brand name Lumify, also as eye drops, in 0.025% solution. It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains f...
Read more Mirvaso Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Brimonidine
Recent Mirvaso Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Drops: 0.2%
- Gel: 0.33%
- Solution: 0.15%, 0.2%
- Solution/drops: 0.025%, 0.1%, 0.10%, 0.15%, 0.2%, 0.20%, 0.5%, 0.50%
NDC Database Records for Mirvaso: (1 result)Sorted by National Drug Code
- 0299-5980 Mirvaso 5 mg/g Topical Gel by Galderma Laboratories, L.p.
Other drugs which contain Brimonidine or a similar ingredient: (8 results)
- ALPHAGAN Brimonidine1 discussion
- ALPHAGAN P Brimonidine
- BRIMONIDINE 1 discussion
- LUMIFY Brimonidine Tartrate
- BRIMONIDINE TARTRATE + TIMOLOL MALEATE
- BRINZOLAMIDE + BRIMONIDINE TARTRATE
- COMBIGAN Brimonidine Tartrate + Timolol Maleate2 discussions
- SIMBRINZA Brinzolamide + Brimonidine Tartrate2 discussions